Previous 10 |
Medical device maker Sight Sciences (SGHT) closed its IPO and raised about $276M in gross proceeds.The eye-disease focused company sold 11.5M common shares, including the exercise in full of the underwriters’ option to by 1.5 additional shares, at $24 each.The company's stock...
MENLO PARK, Calif., July 19, 2021 (GLOBE NEWSWIRE) -- Sight Sciences, Inc., a growth-stage medical device company focused on the development and commercialization of proprietary devices that target the underlying causes of the world’s most prevalent eye diseases, today announced the ...
Sight Sciences has two innovative products to address eye diseases. Commercial traction is good, from a low sales base, as the potential is large. While the valuation is high, the potential is very large as well, making me interested in the name. For further details see: ...
News, Short Squeeze, Breakout and More Instantly...
MENLO PARK, Calif., July 18, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of c...
2024-06-17 00:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
MENLO PARK, Calif., June 10, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences,” or the “Company”), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the standard of ...